Overview
Updated 14 Jul 2026
Scott Woods, MD, is Elizabeth Mears and House Jameson Professor of Psychiatry at Yale University School of Medicine, Department of Psychiatry. The public record shows 742 publications with 35,769 citations (h-index 93), centered on Schizophrenia research and treatment, Mental Health and Psychiatry, Bipolar Disorder and Treatment. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 2 companies, 16 NIH-funded awards (1989–2026).
- Most recent indexed publication: 2026 · Early intervention in psychiatry
- Top research focus: Schizophrenia research and treatment
- 19 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 377.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cga.ct.gov ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Sponsor: Monument Therapeutics Limited
InvestigatorPhase 1/PHASE2RecruitingNCT07226895 - AMP SCZ® Observational Study: PREDICT-DPACC
Sponsor: Brigham and Women's Hospital
InvestigatorActive, not recruitingNCT05905003 - Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
Sponsor: University of California, Los Angeles
InvestigatorActive, not recruitingNCT04338152
Industry payments
Updated 14 Jul 2026
2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:
- RTI SURGICAL, INCProgram year20251 payment
- Phathom Pharmaceuticals, Inc.Program year20241 payment
NIH funding
Updated 14 Jul 2026
16 NIH research awards on record, funded 1989–2026 per NIH RePORTER. The latest:
- ProCAN: Psychosis Risk Outcomes Compound Assessment Network
Yale University
FY2026$17,070,000U01MH137298
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI Canada.
The world journal of biological psychiatry
2026 - Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based Samples.
The American journal of psychiatry
2026 - Value representation in youth psychopathology: evidence of a transdiagnostic risk mechanism for psychosis.
Translational psychiatry
2026
Most-cited worksby citation count (OpenAlex)
- 01Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics2,058 citations2003
- 02Prediction of Psychosis in Youth at High Clinical Risk1,271 citations2008
- 03Multicenter Collaborative Panic Disorder Severity Scale1,016 citations1997
- 04
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
300 George St, New Haven, CT 06511
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership rolesjournal and society appointments
- Director
PRIME Psychosis Prodrome Research Clinic, Yale Department of Psychiatry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Co-developer of the Structured Interview for Psychosis Risk Syndromes (SIPS)
with Thomas McGlashan, Barbara Walsh, and Tandy Miller
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Awards & honorshonors on the public record
- NIH ProCAN grant ($76M, 2023)
Psychosis-Risk Outcomes Compound Assessment Network, co-led with Youngsun Cho
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - 2021 Alexander Gralnick Award for Research in Schizophrenia
American Psychiatric Association Foundation
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apaf.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apaf.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ynhhs.org ↗
Media & interviewspress, podcasts and appearances
- Guest
Medscape "InDiscussion" podcast series on schizophrenia, S2 Episode 4: "Schizophrenia, Clinical High-risk Syndrome, and Psychosis" (with host Dr. John Kane), published August 16
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/scott-woods-md-40901003
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/scott-woods-77ab6823
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
medicine.yale.edu/profile/scott-woods
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Mentions by otherswhere others cite or feature them
- Other
apaf.org/library-archives/galleries/alexander-gralnick-award/scott-woods-m-d-ph-d
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apaf.org ↗ - Other
medscape.com/viewarticle/984484
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harlan Krumholz, MD
Yale University
- 2,898
- publications
- 216
- h-index
- 15
- trials
John Krystal, MD
Yale University
- 1,034
- publications
- 158
- h-index
- 10
- trials
Lajos Pusztai, MD
Yale University
- 1,394
- publications
- 114
- h-index
- 13
- trials
Kevin Sheth, MD
Yale University
- 821
- publications
- 78
- h-index
- 5
- trials